Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Thompson

Showing results (131-140 of 484) with videos related to

Pageof 49
Sort By:
The Journal of Urology|July 12, 2005
Prognostic features in men who died of prostate cancerKadee E Thompson, Javier Hernández, Edith D Canby-Hagino, et al.
Urologic Oncology|April 10, 2003
Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancerIan M Thompson, Joseph A Basler, Robin Leach, et al.
Practical Radiation Oncology|May 4, 2019
Adjuvant and Salvage Radiation Therapy After Prostatectomy: ASTRO/AUA Guideline Amendment, Executive Summary 2018Thomas M Pisansky, Ian M Thompson, Richard K Valicenti, et al.
The Journal of Urology|April 22, 2014
Is there a role for body mass index in the assessment of prostate cancer risk on biopsy?Yuanyuan Liang, Norma S Ketchum, Phyllis J Goodman, et al.
Urology|March 4, 2014
A commentary on PSA velocity and doubling time for clinical decisions in prostate cancerAndrew J Vickers, Ian M Thompson, Eric Klein, et al.
Urologic Oncology|December 25, 2003
Current issues in the management of advanced squamous cell carcinoma of the penisSamira Syed, Tony Y Eng, Charles R Thomas, et al.
Urology|April 21, 2007
Lack of disparity in lower urinary tract symptom severity between community-dwelling non-Hispanic white, Mexican-American, and African-American menAlayne D Markland, Ian M Thompson, Donna P Ankerst, et al.
The Journal of Urology|November 13, 2004
Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of southwest oncology group study 8894Tomasz M Beer, Catherine M Tangen, Lisa B Bland, et al.
The Journal of Urology|June 16, 2009
Chemoprevention of prostate cancerIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.
Journal of Clinical Epidemiology|February 17, 2015
A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validationSonja Grill, Mahdi Fallah, Robin J Leach, et al.
Pageof 49

Showing results (131-140 of 484) with videos related to

Sort By:
Pageof 49
The Journal of Urology|July 12, 2005
Prognostic features in men who died of prostate cancerKadee E Thompson, Javier Hernández, Edith D Canby-Hagino, et al.
Urologic Oncology|April 10, 2003
Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancerIan M Thompson, Joseph A Basler, Robin Leach, et al.
Practical Radiation Oncology|May 4, 2019
Adjuvant and Salvage Radiation Therapy After Prostatectomy: ASTRO/AUA Guideline Amendment, Executive Summary 2018Thomas M Pisansky, Ian M Thompson, Richard K Valicenti, et al.
The Journal of Urology|April 22, 2014
Is there a role for body mass index in the assessment of prostate cancer risk on biopsy?Yuanyuan Liang, Norma S Ketchum, Phyllis J Goodman, et al.
Urology|March 4, 2014
A commentary on PSA velocity and doubling time for clinical decisions in prostate cancerAndrew J Vickers, Ian M Thompson, Eric Klein, et al.
Urologic Oncology|December 25, 2003
Current issues in the management of advanced squamous cell carcinoma of the penisSamira Syed, Tony Y Eng, Charles R Thomas, et al.
Urology|April 21, 2007
Lack of disparity in lower urinary tract symptom severity between community-dwelling non-Hispanic white, Mexican-American, and African-American menAlayne D Markland, Ian M Thompson, Donna P Ankerst, et al.
The Journal of Urology|November 13, 2004
Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of southwest oncology group study 8894Tomasz M Beer, Catherine M Tangen, Lisa B Bland, et al.
The Journal of Urology|June 16, 2009
Chemoprevention of prostate cancerIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.
Journal of Clinical Epidemiology|February 17, 2015
A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validationSonja Grill, Mahdi Fallah, Robin J Leach, et al.
Pageof 49